Nuno Pires is a businessman from South Africa.[1] He is the co-founder of Altis Biologics.[2]

Career

Pires founded Altis Biologics with Nicolaas Duneas[3] in 2002.[4] He is the chief executive of business development at the company.[3]

In 2012 the company won the Africa SMME Awards in the Industrial Sector category.[5]

In 2014, Pires and Duneas won the Innovation Prize for Africa.[6] They received $100.000 for their Osteogenic Bone Matrix (OBM) innovation.[7]

Pires is a board member of the Licensing Executive Society South Africa.[8]

References

  1. ↑ "Previous - Innovation Prize for Africa". innovationprizeforafrica.org. Retrieved 15 December 2017.
  2. ↑ "Pharmaceutical Executive" (PDF). Pharmexec. Retrieved 15 December 2017.
  3. 1 2 "Africa's Red Biotechnology : worldVIEW". www.saworldview.com. Retrieved 15 December 2017.
  4. ↑ Gaylard, Alison; Urban, Boris (2009). Altis Biologics: From Labs to Riches?. London. ISBN 9781473958371.{{cite book}}: CS1 maint: location missing publisher (link)
  5. ↑ "Congratulations to The Innovation Hub resident (tenant) company: Altis Biologics". IT Web. 9 October 2012. Retrieved 15 December 2017.
  6. ↑ "innovation – AMP". qamp.net. October 2014. Retrieved 15 December 2017.
  7. ↑ Rodin, Jonathan. "African company wins innovation award". Engineering News. Retrieved 15 December 2017.
  8. ↑ "Annual Report 2014-15" (PDF). Licensing Executives Society. Retrieved 15 December 2017.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.